We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$52.2M
Cap. Flow
-$11.2M
Cap. Flow %
-3.97%
Top 10 Hldgs %
53.18%
Holding
123
New
20
Increased
19
Reduced
30
Closed
30

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.1M
2
ALT icon
Altimmune
ALT
+$1.99M
3
PFE icon
Pfizer
PFE
+$1.94M
4
PSFE icon
Paysafe
PSFE
+$1.38M
5
F icon
Ford
F
+$1.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$3.33M
2
ABBV icon
AbbVie
ABBV
+$2.82M
3
T icon
AT&T
T
+$1.96M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.83M
5
GLD icon
SPDR Gold Trust
GLD
+$1.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.86%
2 Healthcare 30.79%
3 Technology 11.75%
4 Communication Services 8.8%
5 Financials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOD
26
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
$2.75M 0.97%
270,000
-12,505
-4% -$125K
AMGN icon
27
Amgen
AMGN
$205B
$2.74M 0.97%
11,250
– –
BMY icon
28
Bristol-Myers Squibb
BMY
$129B
$2.71M 0.96%
40,500
+500
+1% +$32.6K
LLY icon
29
Eli Lilly
LLY
$1.02T
$2.58M 0.91%
11,250
– –
PFE icon
30
Pfizer
PFE
$158B
$2.54M 0.9%
65,000
+50,000
+333% +$1.94M
LNSR icon
31
LENSAR
LNSR
$86.5M
$2.42M 0.86%
279,788
+27,463
+11% +$212K
GDXJ icon
32
VanEck Junior Gold Miners ETF
GDXJ
$9.17B
$2.34M 0.83%
50,000
-7,500
-13% -$379K
BABA icon
33
Alibaba
BABA
$270B
$2.27M 0.8%
10,000
+3,000
+43% +$667K
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
$2.13M 0.76%
13,500
– –
MS icon
35
Morgan Stanley
MS
$321B
$2.06M 0.73%
22,500
– –
T icon
36
AT&T
T
$174B
$1.73M 0.61%
79,440
-86,060
-52% -$1.96M
MU icon
37
PUT
Micron Technology
MU
$1.1T
$1.7M 0.6%
20,000
-22,500
-53% -$1.9M
BMY icon
38
CALL
Bristol-Myers Squibb
BMY
$129B
$1.67M 0.59%
+25,000
New +$1.63M
GLD icon
39
CALL
SPDR Gold Trust
GLD
$147B
$1.66M 0.59%
10,000
-5,000
-33% -$850K
AERI
40
DELISTED
Aerie Pharmaceuticals
AERI
$1.46M 0.52%
91,300
-1,200
-1% -$20.6K
SLV icon
41
iShares Silver Trust
SLV
$31.9B
$1.45M 0.51%
60,000
+7,500
+14% +$186K
ALT icon
42
Altimmune
ALT
$624M
$1.44M 0.51%
+145,750
New +$1.99M
F icon
43
Ford
F
$54.9B
$1.34M 0.47%
+90,000
New +$1.2M
PSFE icon
44
Paysafe
PSFE
$329M
$1.33M 0.47%
+9,167
New +$1.38M
BABA icon
45
CALL
Alibaba
BABA
$270B
$1.25M 0.44%
5,500
+3,000
+120% +$667K
AAPL icon
46
CALL
Apple
AAPL
$4.9T
$1.23M 0.44%
9,000
+4,000
+80% +$518K
STEW
47
SRH Total Return Fund
STEW
$1.75B
$1.22M 0.43%
90,000
-19,022
-17% -$255K
TSM icon
48
PUT
TSMC
TSM
$2.23T
$1.2M 0.43%
+10,000
New +$1.17M
ALXN
49
DELISTED
Alexion Pharmaceuticals
ALXN
$1.1M 0.39%
6,000
-6,000
-50% -$1.03M
QCOM icon
50
Qualcomm
QCOM
$203B
$1.07M 0.38%
7,500
– –
1
2
3 4 5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, DCF Advisers held 123 positions worth $282M, up 23% from $230M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

DCF Advisers withdrew a net $11.2M in Q2 2021, closing 30 positions and reducing 30 holdings. Its most notable exit was CVS Health, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DCF Advisers opened a new position in Altimmune worth $1.44M.

  • DCF Advisers's largest Q2 2021 buy was Altimmune: 145,750 shares worth $1.44M.
  • DCF Advisers added most to VanEck Gold Miners ETF in Q2 2021, an estimated $2.1M increase.
  • DCF Advisers's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.33M.
  • DCF Advisers fully exited CVS Health in Q2 2021, selling an estimated $1.62M.
  • DCF Advisers's ten largest holdings make up 53% of its $282M portfolio in Q2 2021.
  • DCF Advisers opened 20 new positions and closed 30 in Q2 2021.
  • DCF Advisers's portfolio value rose 23% quarter-over-quarter to $282M.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.